These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22995189)
1. Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection. Archary D; Rong R; Gordon ML; Boliar S; Madiga M; Gray ES; Dugast AS; Hermanus T; Goulder PJ; Coovadia HM; Werner L; Morris L; Alter G; Derdeyn CA; Ndung'u T Virology; 2012 Nov; 433(2):410-20. PubMed ID: 22995189 [TBL] [Abstract][Full Text] [Related]
2. Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naïve children from India. Makhdoomi MA; Khan L; Kumar S; Aggarwal H; Singh R; Lodha R; Singla M; Das BK; Kabra SK; Luthra K J Gen Virol; 2017 Jul; 98(7):1879-1891. PubMed ID: 28696188 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression. Chuenchitra T; Wasi C; Louisirirojchanakul S; Nitayaphan S; Sutthent R; Cox JH; De Souza MS; Brown AE; Birx DL; Polonis VR AIDS Res Hum Retroviruses; 2003 Apr; 19(4):293-305. PubMed ID: 12804005 [TBL] [Abstract][Full Text] [Related]
9. Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India. Andrabi R; Bala M; Kumar R; Wig N; Hazarika A; Luthra K PLoS One; 2012; 7(8):e43704. PubMed ID: 22952740 [TBL] [Abstract][Full Text] [Related]
10. B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses. Oballah P; Flach B; Eller LA; Eller MA; Ouma B; de Souza M; Kibuuka HN; Wabwire-Mangen F; Brown BK; Michael NL; Robb ML; Montefiori D; Polonis VR PLoS One; 2011; 6(8):e22653. PubMed ID: 21886768 [TBL] [Abstract][Full Text] [Related]
11. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection. Gray ES; Madiga MC; Hermanus T; Moore PL; Wibmer CK; Tumba NL; Werner L; Mlisana K; Sibeko S; Williamson C; Abdool Karim SS; Morris L; J Virol; 2011 May; 85(10):4828-40. PubMed ID: 21389135 [TBL] [Abstract][Full Text] [Related]
12. Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy. Hu X; Hong K; Zhao C; Zheng Y; Ma L; Ruan Y; Gao H; Greene K; Sarzotti-Kelsoe M; Montefiori DC; Shao Y J Gen Virol; 2012 Oct; 93(Pt 10):2267-2278. PubMed ID: 22791603 [TBL] [Abstract][Full Text] [Related]
13. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk. Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR J Virol; 2017 May; 91(9):. PubMed ID: 28202762 [TBL] [Abstract][Full Text] [Related]
14. HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes. Ditse Z; Muenchhoff M; Adland E; Jooste P; Goulder P; Moore PL; Morris L J Virol; 2018 Sep; 92(17):. PubMed ID: 29950423 [TBL] [Abstract][Full Text] [Related]
15. Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop. Moore PL; Gray ES; Sheward D; Madiga M; Ranchobe N; Lai Z; Honnen WJ; Nonyane M; Tumba N; Hermanus T; Sibeko S; Mlisana K; Abdool Karim SS; Williamson C; Pinter A; Morris L; J Virol; 2011 Apr; 85(7):3128-41. PubMed ID: 21270156 [TBL] [Abstract][Full Text] [Related]
16. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques. Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847 [TBL] [Abstract][Full Text] [Related]
17. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers". Sun Z; Li J; Hu X; Shao Y; Zhang MY Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672 [TBL] [Abstract][Full Text] [Related]
18. Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection. Diomede L; Nyoka S; Pastori C; Scotti L; Zambon A; Sherman G; Gray CM; Sarzotti-Kelsoe M; Lopalco L J Virol; 2012 Apr; 86(8):4129-38. PubMed ID: 22301151 [TBL] [Abstract][Full Text] [Related]
19. Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma. Sajadi MM; Lewis GK; Seaman MS; Guan Y; Redfield RR; DeVico AL J Virol; 2012 May; 86(9):5014-25. PubMed ID: 22379105 [TBL] [Abstract][Full Text] [Related]
20. Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India. Makhdoomi MA; Singh D; Nair Pananghat A; Lodha R; Kabra SK; Luthra K Virology; 2016 Dec; 499():105-113. PubMed ID: 27643887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]